The Institute for Basic Science (IBS) is organizing the IBS-KAI Conference from July 12th to 14th at the Hotel ICC Daejeon.
Bristol Myers pays $350M upfront for rights to heart drug Camzyos in Asia
Bristol Myers Squibb is setting up a deal with Shanghai-based LianBio to get the rights to the heart drug Camzyos in China and several other